According to the company, the committee said that the safety concerns warrant reevaluation of the study design, particularly ...
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the stocks that will double in 2026. On December 9, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Gossamer Bio, with a price target of $15.
Relay shares had been under pressure since October when initial results from VIKTORIA-1’s wild-type cohort exceeded market ...
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Wave Life Sciences Ltd. tops our list for being one of the most promising stocks. TheFly reported on ...